Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dooley

Showing results (81-90 of 370) with videos related to

Pageof 37
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2013
Dosing of cytotoxic chemotherapy: impact of renal function estimates on doseM J Dooley, S G Poole, D Rischin
The Physician and Sportsmedicine|July 22, 2016
Hamstring/Quadriceps Strength Ratios in Collegiate Middle-Distance and Distance RunnersA Morris, L Lussier, G Bell, et al.
Journal of the American Chemical Society|September 28, 2006
RNA-templated semiconductor nanocrystalsNan Ma, Chad J Dooley, Shana O Kelley
The Journal of Bone and Joint Surgery. British Volume|November 1, 1980
Subcutaneous rupture of the tendon of tibialis anteriorB J Dooley, P Kudelka, M B Menelaus
Neuroscience Letters|June 25, 1993
The non-dihydropyridine L-type voltage-sensitive calcium channel activator FPL 64176 enhances K(+)-evoked efflux of [3H]norepinephrine from rat neocortical slicesT Ginap, D J Dooley, T J Feuerstein
Clinical Orthopaedics and Related Research|February 1, 1993
Multiple hereditary exostoses. An epidemiologic study of an isolated community in ManitobaB Black, J Dooley, A Pyper, et al.
Journal of Child Neurology|July 1, 1996
Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trialsP Camfield, K Gordon, J Dooley, et al.
The Annals of Pharmacotherapy|January 29, 2003
Comment: hospital admissions resulting from preventable adverse drug reactionsPhyllis M Lau, Kay Stewart, Michael J Dooley
European Journal of Pharmacology|October 14, 1986
CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptorsD J Dooley, H Bittiger, N C Reymann
Targeted Oncology|March 30, 2017
Erratum to: Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case ReportAndrew J Dooley, Avinash Gupta, Mark R Middleton
Pageof 37

Showing results (81-90 of 370) with videos related to

Sort By:
Pageof 37
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 10, 2013
Dosing of cytotoxic chemotherapy: impact of renal function estimates on doseM J Dooley, S G Poole, D Rischin
The Physician and Sportsmedicine|July 22, 2016
Hamstring/Quadriceps Strength Ratios in Collegiate Middle-Distance and Distance RunnersA Morris, L Lussier, G Bell, et al.
Journal of the American Chemical Society|September 28, 2006
RNA-templated semiconductor nanocrystalsNan Ma, Chad J Dooley, Shana O Kelley
The Journal of Bone and Joint Surgery. British Volume|November 1, 1980
Subcutaneous rupture of the tendon of tibialis anteriorB J Dooley, P Kudelka, M B Menelaus
Neuroscience Letters|June 25, 1993
The non-dihydropyridine L-type voltage-sensitive calcium channel activator FPL 64176 enhances K(+)-evoked efflux of [3H]norepinephrine from rat neocortical slicesT Ginap, D J Dooley, T J Feuerstein
Clinical Orthopaedics and Related Research|February 1, 1993
Multiple hereditary exostoses. An epidemiologic study of an isolated community in ManitobaB Black, J Dooley, A Pyper, et al.
Journal of Child Neurology|July 1, 1996
Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trialsP Camfield, K Gordon, J Dooley, et al.
The Annals of Pharmacotherapy|January 29, 2003
Comment: hospital admissions resulting from preventable adverse drug reactionsPhyllis M Lau, Kay Stewart, Michael J Dooley
European Journal of Pharmacology|October 14, 1986
CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptorsD J Dooley, H Bittiger, N C Reymann
Targeted Oncology|March 30, 2017
Erratum to: Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case ReportAndrew J Dooley, Avinash Gupta, Mark R Middleton
Pageof 37